ArticleProstate cancer and prostatic diseases2020

Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial.

Alberto Martini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.